Explore Our Network

10x National Security, LLC is dedicated to enhancing national security through the operationalization of new and emerging technologies. The company focuses on creating exceptional user experiences, lowering barriers to technology access, and fostering a culture of radical transparency and collaboration. Their mission is to ensure that future generations benefit from improved national security measures.

12-15 Molecular Diagnostics is an early-stage biotechnology company dedicated to revolutionizing testing and diagnostics with faster, more accurate, and affordable solutions. Their Veralize platform enables early detection of infections and chemical contaminants in fluids, including water, blood, saliva, and more, with results within 10 minutes. The company aims to improve public health, water quality, biodefense, and early disease detection through innovative nanotechnology and partnerships.

149 Medical is dedicated to improving outcomes for premature infants through innovative, life-changing technology. Their primary focus is on reducing morbidity and mortality by providing continuous, real-time monitoring of cerebral blood flow to detect and mitigate risks such as ventricular hemorrhage. Their flagship device, NIRDS1, is a non-invasive intracranial blood flow sensor validated in over 1,000 children, currently in clinical evaluation, and licensed exclusively from Massachusetts General Hospital. The company's mission is to shift the standard of care from traditional, less effective methods to advanced, early detection technologies, ultimately decreasing disabilities and improving long-term health outcomes for the smallest and most vulnerable patients.

1910 Genetics is a biotechnology company focused on advancing small and large molecule drug discovery using a multimodal AI platform integrated with laboratory automation. Their mission is to make undruggable targets a thing of the past, leveraging proprietary data streams and computational technologies to develop novel therapeutics across various disease areas. They collaborate with leading pharma and tech partners, and are backed by prestigious investors. The company emphasizes the integration of biology, AI, and computation to accelerate drug discovery and development.

1 Globe Health Institute is dedicated to providing health-related services and information. They focus on science and technology in healthcare, and aim to be a great place to work. Their mission includes offering accessible health solutions and fostering a positive work environment.

1MED is a global Contract Research Organization providing high-quality regulatory, clinical, and post-market services for medical devices, pharmaceuticals, and biotech companies. Established in 2014 and headquartered in Agno, Switzerland, it specializes in supporting innovative medical device development, ensuring compliance with MDR and IVDR regulations, and facilitating product certification and market access. With a focus on innovation, reliability, and comprehensive support across all phases of product lifecycle, 1MED aims to transform complex regulatory processes into efficient pathways for medical technology commercialization.

Provider of a field-deployable powder screening test kit used by first responders to rapidly screen suspicious powders for potential biological agents. Produces self-contained, single-use screening kits that use a protein-detection assay combined with a pH test to provide visual results in minutes. The product has been independently evaluated by national laboratories, holds issued patents, and has received a DHS SAFETY Act designation.

206 Ortho is a company dedicated to developing and commercializing innovative bioresorbable, high-strength materials for bone repair. Their mission is to improve patient care, reduce treatment costs, and transform the orthopedic market by replacing permanent metal implants with resorbable solutions. They focus on creating versatile, nature-mimicking materials that support natural healing and eliminate the need for removal surgeries, aiming to make healthcare more affordable and effective globally.

20n Bio is a VC-backed startup dedicated to discovering cyclic peptides for therapeutic use. Based in the Greater Philadelphia region, their mission is to address unmet medical needs by leveraging high-throughput screening and chemical optimization to develop peptide drugs across various therapeutic areas. They have developed a proprietary platform capable of screening trillions of peptides to identify potent candidates and have built partnerships with pharmaceutical and biotech companies.

21st Century Medicine is a research and development company specializing in advanced biopreservation technologies, including hypothermic preservation, cryopreservation, and vitrification. Their mission is to develop innovative solutions for the protection, preservation, transportation, and storage of living systems, with applications spanning from biopharmaceuticals to organ banking and reproductive technologies. They focus on creating custom solutions, developing preservation protocols, and advancing the science of cryobiology to improve patient care and biomedical research.

2Blades is a non-profit, agbiotech company dedicated to preventing pre-harvest crop losses by translating scientific discoveries into resilient crop varieties. They support both commercial and smallholder farmers by bridging public and private resources to maximize agricultural innovation success. With over 20 years of experience, they focus on diseases affecting crops like soybean, potato, wheat, and corn, partnering with foundations, companies, and organizations to create a sustainable and productive global food supply.

2N Pharma is an innovative biotech company dedicated to developing treatments for neurodegenerative diseases, with a focus on ALS, Parkinson's disease, and frontotemporal dementia. They utilize a groundbreaking approach targeting mitochondrial dysfunction and lipid metabolism, supported by extensive research and collaborations. Their mission is to find effective cures for these incurable conditions through novel small molecule therapeutics, with ongoing clinical and preclinical development, and active engagement in scientific research, funding, and industry events.

2seventy bio is a company dedicated to outmaneuvering cancer and providing more time for patients. Inspired by the maximum speed of translating human thought into action, the company focuses on scientific expertise in gene therapy and oncology. It was spun out of bluebird bio, Inc., and has a heritage rooted in deep care for patients, thought leadership, and scientific innovation. The company collaborates with Bristol Myers Squibb and other industry partners, and is committed to promoting health equity and access to care. Its mission is to deliver more time to people living with multiple myeloma through innovative therapies, primarily focusing on the drug Abecma.

34 Lives is dedicated to reducing the transplant waiting list in the US by developing innovative technology and services that extend the safe preservation times for unused kidneys. Their mission is to bring the number of patients removed from the transplant list due to death or sickness down to zero, by rescuing and reviving donor kidneys to save lives.

Consulting practice that connects innovators with national and global security needs by advising on chemical, biological, radiological, and nuclear (CBRN) threats, medical countermeasure strategies, diagnostics and surveillance, and federal engagement. Combines operational special-operations experience and intelligence-informed threat analysis with technical program management and federal acquisition expertise to position technologies for adoption by defense, public health, and intelligence customers.

3B Scientific is dedicated to providing high-quality educational models, simulators, and teaching materials across various scientific and medical fields. Their mission is to support education, training, and research through innovative, detailed, and realistic anatomical, scientific, and health-related models and simulators, including a wide range of products for medical training, health education, scientific research, and more. They aim to be a comprehensive resource for educational institutions, healthcare providers, and scientific organizations worldwide.

Clinical development company developing a frameless, non-hormonal intrauterine drug-delivery platform that uses multiple small magnetic implant units which self-assemble in the uterine cavity, a flexible insertion applicator to reduce insertion steps, and a magnetic retrieval tool for removal. The lead program is in preclinical development with IND preparation and planned first-in-human (Phase 1) clinical studies. The company has completed seed financing and is raising a Series A to support clinical entry and has relocated corporate headquarters to a flexible lab/innovation facility in Baltimore to support scale-up and collaborations.

Engineering company specializing in advanced signal processing and spectrum analysis software and integrated hardware systems. Provides real-time and offline RF/spectrum analytics, geolocation and direction-finding capabilities, multi-receiver SDR integration, system-level hardware platforms, field support, and customized training for government and commercial customers.

3E Bioventures Capital is a life-sciences focused venture capital fund that invests in global health innovators. The firm targets Biotech (new drugs, new modalities, drug-discovery platforms) and TechBio (the intersection of biology and technology). 3E describes a science-driven, entrepreneur-friendly investment approach and partners with companies and research institutions to develop drugs or products addressing unmet medical needs. The firm’s motto is 3E: Expertise, Efficiency, Execution.

3i Diagnostics is dedicated to developing rapid, affordable, and easy-to-use diagnostic technologies to identify infectious microbes and antimicrobial resistant strains in less than an hour. Their mission is to improve patient outcomes, reduce treatment costs, and combat antibiotic resistance by providing clinicians with timely and precise microbial identification. They are innovating with platforms like Biospectrix™ and developing assays for blood, sputum, urine, and other samples, aiming to revolutionize infection diagnosis and antimicrobial stewardship. The company is also working on launching an RUO contamination detection kit for biologics and is in talks with several companies to use their sample prep technology as a front-end addition to other detection methods, including sequencing, flow cytometry, mass spectrometry, and PCR. They are developing a database of IR signatures for pathogens, with potential to identify specific strains and resistance, focusing initially on prevalent bacterial strains causing sepsis.

3M Ventures is the corporate venturing arm of 3M Company. It provides minority growth investments and incubates new businesses that align with 3M's strategic priorities. The team leverages 3M technology platforms, laboratories, manufacturing, commercial expertise and global customer networks to support partner companies.